Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period
Primary Purpose
Dyslipidemia
Status
Completed
Phase
Phase 1
Locations
Brazil
Study Type
Interventional
Intervention
Eggplant extract
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Dyslipidemia focused on measuring eggplant, dyslipidemia, postprandial lipemia
Eligibility Criteria
Inclusion Criteria:
- Baseline clinical evaluation conducted by a doctor
- Informed consent form
Exclusion Criteria:
- Diabetes Mellitus
- Smoking
- Use of hypolipidemic medication
Sites / Locations
- Hospital de Clínicas de Porto Alegre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Eggplant extract
Placebo
Arm Description
Outcomes
Primary Outcome Measures
Lipid profile
Secondary Outcome Measures
Anthropometric measures
Full Information
NCT ID
NCT00845637
First Posted
February 16, 2009
Last Updated
February 20, 2009
Sponsor
Hospital de Clinicas de Porto Alegre
1. Study Identification
Unique Protocol Identification Number
NCT00845637
Brief Title
Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period
Official Title
Effect of the Oral Administration of Eggplant Extract Capsules on Lipid Profile During Fasting and Postprandial Period: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2009
Overall Recruitment Status
Completed
Study Start Date
March 2004 (undefined)
Primary Completion Date
March 2007 (Actual)
Study Completion Date
March 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study was to assess the effect of eggplant extract capsules on the lipid profile of healthy individuals after an oral lipid overload test in a randomized, double-blind, placebo-controlled clinical trial.
Detailed Description
Dry eggplant extract(Solanum melongena) has been used by the population as an alternative treatment for dyslipidemia. It is a vegetable rich in flavonoids, which are polyphenol anti-oxidants found in foods. Studies suggest an inverse relationship between the ingestion of foods rich in flavonoids and mortality from coronary artery disease. The aim of this study was to assess the effect of administering eggplant extract capsules on the lipid profile of healthy individuals after an oral lipid overload test.
Participants underwent a baseline clinical evaluation conducted by a doctor, who assessed whether the volunteer was apt to participate in the study. Diabetics, smokers and users of hypolipidemic medication were excluded. After signing an informed consent form, 59 healthy volunteers of both genders were randomized to take either capsules containing 450 mg of dry eggplant extract or placebo. Both interventions were administered in quantities of two capsules, twice a day, for 14 days, and both patient and doctor were unaware of the drug in use.
The main outcome measure was lipid profile, which was checked during fasting on days 0 and 14, and also during postprandial period on the 14th day, when participants underwent a lipid overload test immediately after ingesting 900 mg of eggplant extract or placebo, as per prior randomization. The nutritional analysis of the meal contained 361 kcal and 22.5g of total fat, 14.5 g of which was saturated and 251mg of cholesterol. Laboratory exams were taken (total cholesterol, triglycerides, HDL-C). LDL-C was calculated according to the Friedewald formula: LDL-C = CT - HDL-C - TG/5. The nutritional value of food records was conducted with the help of Diet Win for Windows nutritional evaluation software.
Anthropometric evaluation was also performed, including body weight, height and abdominal circumference, at baseline and on day 14, by the same investigator, blinded to the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyslipidemia
Keywords
eggplant, dyslipidemia, postprandial lipemia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
59 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Eggplant extract
Arm Type
Active Comparator
Arm Title
Placebo
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Eggplant extract
Intervention Description
Dry eggplant extract in two 450mg capsules, twice a day (before the main meals) for fourteen days.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo in two 450mg capsules, twice a day (before the main meals) for fourteen days.
Primary Outcome Measure Information:
Title
Lipid profile
Time Frame
Before treatment and twice on the fouteenth day, before and 2 hours after lipid overload test
Secondary Outcome Measure Information:
Title
Anthropometric measures
Time Frame
Before treatment and on day fourteen
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Baseline clinical evaluation conducted by a doctor
Informed consent form
Exclusion Criteria:
Diabetes Mellitus
Smoking
Use of hypolipidemic medication
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paulo D Picon, MD, PhD
Organizational Affiliation
Hospital de Clínicas de Porto Alegre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande do Sul
Country
Brazil
12. IPD Sharing Statement
Learn more about this trial
Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period
We'll reach out to this number within 24 hrs